First patient with Parkinson's disease operated on in Yalta
CrimeaPRESS reports:
Viktor Kuleshov became the first patient who underwent a unique operation in the Department of Neurosurgery of the branch of the Federal Research and Clinical Center of the Federal Medical and Biological Agency of Russia in Crimea — implantation of a deep brain stimulation system. This method of treatment of Parkinson’s disease has not previously been used in the Crimea. Today, such operations are put on stream — in less than three weeks, the multidisciplinary team of physicians of the branch has already performed 6 such interventions, doctors are preparing six more patients for this procedure. The man is being monitored by doctors, and the other day he was examined by a neurophysiologist-neurologist Lidia Mishnyakova (pictured).
The patient came to control evaluation of stimulation parameters. We looked at the condition of the postoperative sutures, everything is calm here, there is no suppuration. We also checked how the generator works, whether it is necessary to change the parameters that were set after the operation. The patient has a good positive dynamics — increased range of motion, he walks more confidently, decreased general stiffness. After examinations, it was decided to slightly reduce the concentration of drugs taken by the patient, and leave the generator parameters unchanged.— says Lidia Mishnyakova.
Viktor Kuleshov will be under the supervision of a neurophysiologist for another year. Doctors must clearly understand under what parameters the effect of stimulation will be most beneficial. The man himself says that he has long studied how to minimize the complications of Parkinson’s disease. He has been suffering from this disease since 2017. And as soon as I found out that new methods of treating Parkinson’s disease were being introduced in Yalta, I immediately agreed to a high-tech operation.
The patient himself speaks about his well-being here — https://www.youtube.com/watch?v=3CQwgFLzPxU
News of the Crimea | CrimeaPRESS
Comments are closed.